Article
Peroxisome proliferator-activated receptor-delta genotype influences metabolic phenotype and may influence lipid response to statin therapy in humans: a genetics of diabetes audit and research Tayside study.
The Journal of clinical endocrinology and metabolism - 1 Apr 2010
Burch Lindsay R, Donnelly Louise A, Doney Alex S F, Brady Jeffrey, Tommasi Anna M, Whitley Adrian L, Goddard Catharine, Morris Andrew D, Hansen Michael K, Palmer Colin N A
Abstract excerpt
CONTEXT: Previous studies have identified a single-nucleotide polymorphism in the gene encoding peroxisome proliferator-activated receptor-delta (PPARD), rs2016520, that is associated with changes in metabolic disease in some but not all studies, which suggests that PPARD agonists may have therap...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
